Page last updated: 2024-11-05

trimellitic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trimellitic acid (TMA) is a white crystalline solid with the formula C9H6O6. It is a tribasic acid, meaning it has three acidic protons that can be donated. TMA is an important industrial chemical used in the production of plasticizers, resins, and flame retardants. TMA is a key intermediate in the production of polyester resins, which are used in a variety of applications, including automotive parts, fiberglass reinforced plastics, and coatings. TMA is synthesized from the oxidation of xylene or pseudocumene. TMA is a strong acid that can cause irritation to the skin, eyes, and respiratory system. It is also a flammable solid. TMA is studied for its use in a variety of applications, including the production of high-performance polymers, flame retardants, and plasticizers. TMA is also being investigated for its potential use in the development of new energy storage devices.'

trimellitic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trimellitic acid : Benzene substituted at the 1,2, and 4 positions by carboxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10708
CHEMBL ID296024
CHEBI ID166055
SCHEMBL ID23861
MeSH IDM0063698

Synonyms (57)

Synonym
EU-0066742
AC-12673
unii-7nvy29mq5f
7nvy29mq5f ,
4-09-00-03746 (beilstein handbook reference)
1,2,4-benzenetricarboxylic acid
benzene-1,2,4-tricarboxylic acid
einecs 208-432-3
4-carboxyphthalic acid
1,4,5-benzenetricarboxylic acid
brn 2214815
1,3,4-benzenetricarboxylic acid
nsc 72986
1,2,4-tricarboxybenzene
1,4-tricarboxybenzene
nsc-72986
1,4-benzenetricarboxylic acid
528-44-9
trimellitic acid
wln: qvr bvq dvq
nsc72986
inchi=1/c9h6o6/c10-7(11)4-1-2-5(8(12)13)6(3-4)9(14)15/h1-3h,(h,10,11)(h,12,13)(h,14,15
1,2,4-benzenetricarboxylic acid, >=99%
NCGC00164021-01
B0042
CHEMBL296024
chebi:166055 ,
HMS1668A11
benzene-1,2,4-tricarboxylic acid;1,2,4-benzenetricarboxylic acid
A7713
NCGC00164021-02
1,2,4-benzenetricarboxylicacid
dtxsid3021487 ,
dtxcid101487
cas-528-44-9
tox21_302990
NCGC00256331-01
tox21_201939
NCGC00259488-01
STL163328
BBL011593
AKOS005716310
FT-0622640
trimellitic acid [mi]
SCHEMBL23861
mfcd00002470
CCG-245088
SY010192
AS-17898
Q2001805
AMY13397
AC2198
EN300-24942
GHM ,
CS-W015125
benzene-1,2,4-tricarboxylic acid, trimellitic acid
Z203045298
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tricarboxylic acidAn oxoacid containing three carboxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency35.57420.007215.758889.3584AID1224835
GLI family zinc finger 3Homo sapiens (human)Potency62.00190.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency31.07460.003041.611522,387.1992AID1159552
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.81800.000229.305416,493.5996AID743069; AID743075
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency1.54860.023723.228263.5986AID743222
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.30600.000323.4451159.6830AID743065
heat shock protein beta-1Homo sapiens (human)Potency22.19660.042027.378961.6448AID743210
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID227718Binding energy by using the equation deltaG obsd = -RT ln KD1984Journal of medicinal chemistry, Dec, Volume: 27, Issue:12
Functional group contributions to drug-receptor interactions.
AID631927Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhagic lesion formation compound incubated with venom for 10 mins and administered subcutaneously measured after 24 hrs2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID631930Dissociation constant, pKa of the compound2011Bioorganic & medicinal chemistry, Dec-01, Volume: 19, Issue:23
Benzenepolycarboxylic acids with potential anti-hemorrhagic properties and structure-activity relationships.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (31.25)18.7374
1990's1 (6.25)18.2507
2000's3 (18.75)29.6817
2010's7 (43.75)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.01

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.01 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index57.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.01)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.88%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (5.88%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]